Valeant Sells Aussie Pharma Biz To PE Shops For $930M
Pacific Equity Partners and The Carlyle Group LP have agreed to pay $930 million to buy from Valeant Pharmaceuticals International Inc. a business that sells and distributes prescription and over-the-counter products...To view the full article, register now.
Already a subscriber? Click here to view full article